The USE MODIFIED RISK STRATIFICATION mSMART 3.0 IN REAL CLINIC PRACTICE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

Hematological Oncology - United Kingdom
doi 10.1002/hon.239_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Coronary Risk Stratification of Patients With Newly Diagnosed Heart Failure

Open Heart
Cardiovascular MedicineCardiology
2019English

Daratumumab in Untreated Newly Diagnosed Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2019English

Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Stem Cells International
Cell BiologyMolecular Biology
2012English

Prognostic Nomogram for the Overall Survival of Patients With Newly Diagnosed Multiple Myeloma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Chromosome 1 Abnormalities in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Therapies

Haematologica
Hematology
2014English

Improvement in Renal Function and Its Impact on Survival in Patients With Newly Diagnosed Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2015English

Quantification of Clonal Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Implications for Redefining High-Risk Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Novel Therapies in Multiple Myeloma for Newly Diagnosed Nontransplant Candidates

Cancer Journal
Cancer ResearchOncology
2009English

The Impact of ASCT on Patients With Newly Diagnosed Multiple Myeloma Who Receive RVD Induction

Journal of Hematological Malignancies
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy